I am honored to release this interview with Doug Oliver, Founder of the Regenerative Outcomes Foundation. Doug has an incredible story of being a stem cell patient, turned renowned advocate and consultant within the field of regenerative medicine. In this interview, we explore what inspired him to establish the Regenerative Outcomes Foundation, his awards and accolades within the field, the critical importance of advocacy work, and so much more. Enjoy! [Read more…]
BioInformant's Founder, Cade Hildreth, has interviewed hundreds of key opinion leaders (KOL's) from across the stem cell industry.
Pluristem Therapeutics, Interview with Yaky Yanay, President and Co-CEO
Pluristem Therapeutics (PSTI) is a clinical-stage company that is a proprietary 3D manufacturing technology to develop placental cell therapies for conditions that include ischemia, muscle injury, and exposure to radiation. I had the honor of interviewing Mr. Yaky Yanay, President and Co-CEO of Pluristem Therapeutics.
In this interview, we discuss the history of Pluristem Therapeutics, its clinical-stage products, intellectual property (IP) portfolio, marketing strategy and future directions.
Enjoy these insights into Pluristem Therapeutics, a world-class leader in cell therapy manufacturing and placental-derived products. [Read more…]
Interview with Kyle Cetrulo, CEO of AuxoCell Laboratories
This is an interview with Kyle Cetrulo, Founder and CEO of AuxoCell Laboratories, a company specializing in solid tissue processing using its AC:Px System. In addition to heading Auxocell and being a thought-leader on perinatal stem cells, Kyle is an organizer for the upcoming 2nd Annual Perinatal Stem Cell Society Conference that will take place each March in Aspen, CO.
[Read more…]
Interview with Dr. Desirée Cox, CEO of the HEALinc Future Health Innovation Summit

Dr. Desirée Cox, MD, PhD is a thought leader in future health innovation. She is a Rhodes Scholar, medical doctor, published author and contemporary visual artist whose work has been shown in exhibitions all over the world. She is also the founder and CEO of The HEALinc Innovation Incubator and the HEALinc Future Health Innovation Summit.
The 2018 Inaugural Summit takes place this year, October 7th-9th at the Melia Hotel in Nassau, Bahamas.
Dr. Cox has earned degrees from McGill University (Canada), Oxford University (UK) and Cambridge University (UK). She is an honorary professor of the Rutgers Graduate School of Biomedical Sciences and a former university professor and honorary professor of creativity, health and wellbeing at the University of Exeter (UK). She has also been recognized by the British Medical Journal as a ‘Renaissance Woman’ for her application of psychological medicine to real world problems. [Read more…]
Dr. Paul Wotton on the Future of Cynata Therapeutics’ Novel iPSC-Derived MSCs
This is an interview with Dr. Paul Wotton, who joined Cynata Therapeutics Board of Directors in June, 2016. Dr. Wotton was previously President and CEO of Ocata Therapeutics, Inc. (NASDAQ: OCAT) joining the company in July 2014 and managing it through an all-cash take-over by Astellas Pharma valued at $379 million. [Read more…]
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 15
- Next Page »




